USPTO serial 79079370
CELLTRION
Reviewed by CopyMark Law Group
Reg. 3936764Status 739Registered
- Filing date
- Status date
- Registration date
- Mar 29, 2011
- Examiner
- EULIN, INGRID C
- Law office
- GENERIC WEB UPDATE
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with CELLTRION?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | [ Vaccines; medicines for sensory organs, namely, pharmaceutical preparations for the treatment and prevention of disorders of sensory organ; agents affecting peripheral nervous system, namely, pharmaceutical preparations for the treatment and prevention of disorders of the peripheral nervous system; ] agents for immunity adjustment, namely, pharmaceutical preparations for the [ prevention and ] treatment of disorders of the immune system; biological preparations for medical purposes; [ amino acids for medical purposes; antibiotic preparations; agents for respiratory organs, namely, pharmaceutical preparations for the prevention and treatment of disorders of respiratory organs; chemotherapeutics; reagents for measuring Hepatitis B Surface antibody, namely, medical diagnostic reagents for detecting Hepatitis B surface antibody; diagnostic preparations for medical use; AIDS, acquired immune deficiency syndrome diagnostic agents, namely, diagnostic preparation for medical use; AIDS, acquired immune deficiency syndrome vaccines; agents affecting central nervous system, namely, pharmaceutical preparations for the treatment and prevention of disorders of the nervous system; veterinary vaccines; agents for tumor treatment, namely, pharmaceutical preparations for the treatment of tumor; agents for urogenital organs, namely, pharmaceutical preparations for the treatment and prevention of disorders of urogenital organs; kits for protein test, namely, diagnostic kits, namely, primary reagents for detecting the presence of a protein related to a disease; kits for gene test, namely, diagnostic kits, namely, primary reagents for detecting the presence of a gene related to a disease; ] biopharmaceuticals for the treatment [ and prevention ] of [ infectious diseases, tumor-related diseases, ] auto-immune diseases, [ hormone-deficiency diseases; ] biopharmaceutical preparations, namely, polypeptides, proteins, monoclonal antibodies, [ hormones for the treatment and prevention of infectious diseases, tumor-related diseases, auto-immune diseases, hormone deficiency diseases; ] biotherapeutic preparations and substances for medical purposes; biotechnological preparations for medical purposes; pharmaceuticals [ ; chemical preparations for pharmaceutical purposes, namely, chemical reagents for medical purposes; chemico-pharmaceutical preparations ] | ACTIVE | — |
| 035 | Wholesale distributorships featuring pharmaceutical products; retail store services featuring pharmaceutical products; business intermediary services in the field of pharmaceutical products; wholesale distributorships featuring biopharmaceutical products; retail store services featuring biopharmaceutical products; business intermediary services in the field of biopharmaceutical products | ACTIVE | — |
| 040 | Treatment of biopharmaceutical materials, namely, processing finished products from raw biopharmaceutical materials; treatment service of biopharmaceutical materials for others, namely, processing finished products from raw biopharmaceutical materials for others; contract manufacturing service for others in the field of biopharmaceuticals; contract manufacturing service in the field of pharmaceuticals | ACTIVE | — |
| 042 | Pharmaceutical research and development; [ bacteriological research; biological research; research and development for new products for others; material testing; chemistry services, namely, chemistry consultation; chemical research and analysis; technology outsourcing services on biopharmaceuticals manufacturing, namely, conducting biopharmaceutical research services for others; consulting services in the field of biotechnology; pharmaceutical drug development services with animal cell; scientific research related to genetically modified plant; biotechnology research; ] biopharmaceutical research and development [ ; medical product testing; technology outsourcing services on selecting medicines, namely, conducting pharmaceutical research services for others ] | ACTIVE | — |
| 044 | [ Rental of medical and health care equipment; medical product information, namely, providing an interactive holistic web site featuring health information and patient initiated, patient authorized, fee-for-service, holistic approach distance healing sessions based on the patient's specific set of symptoms, medical profile and medical record analysis and patient benefit information concerning organic and holistic products and services; medical clinics, namely, conducting clinical trials of new products for medical purposes; hospitals; medical assistance services; biopharmaceutical consulting service] | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by CELLTRION, INC.
- Other trademarks owned by Celltrion Holdings Co.,Ltd.
- Other trademarks owned by CELLTRION, INC.
- Other trademarks owned by CELLTRION, INC.
- Other trademarks in Class 005
- Other trademarks in Class 035
- Other trademarks in Class 040
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named CELLTRION
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 21, 2023 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Dec 2, 2022 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jul 9, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 12, 2021 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Apr 1, 2021 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Apr 1, 2021 | C75A | REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Mar 24, 2021 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Mar 22, 2021 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Mar 22, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 22, 2021 | EWOR | TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED | — |
| Mar 22, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 22, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 22, 2021 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Mar 29, 2020 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Dec 5, 2019 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Apr 6, 2018 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Feb 22, 2018 | INPS | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Feb 22, 2018 | INPC | INVALIDATION PROCESSED | — |
| Feb 15, 2018 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jun 15, 2017 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Jun 15, 2017 | 71.P | REGISTERED - PARTIAL SEC 71 ACCEPTED | — |
| Jun 15, 2017 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Mar 28, 2017 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Mar 26, 2015 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Feb 25, 2013 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 12, 2012 | LIMN | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| May 25, 2012 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Jun 30, 2011 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jun 30, 2011 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 29, 2011 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 29, 2011 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 11, 2011 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 11, 2011 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 7, 2010 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Dec 7, 2010 | ALIE | ASSIGNED TO LIE | — |
| Nov 15, 2010 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 12, 2010 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 11, 2010 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 11, 2010 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 11, 2010 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 12, 2010 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 12, 2010 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 12, 2010 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 10, 2010 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 10, 2010 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 10, 2010 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 10, 2010 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 19, 2010 | UNDN | UNDELIVERABLE MAIL - NO ACTION TAKEN | — |
| Apr 9, 2010 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 19, 2010 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 17, 2010 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 17, 2010 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 17, 2010 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 16, 2010 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 15, 2010 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 15, 2010 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 11, 2010 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |